Novel role of serum albumin imidase activity in the formation of BI 761036 (M232), a major metabolite of iclepertin
{{output}}
Iclepertin was a promising drug candidate being developed for the treatment of cognitive impairment associated with schizophrenia. Interestingly, the predominant major metabolite in vivo in humans, BI 761036 (M232), was not observed after incubations in hepato... ...
